Taiwan Bio Therapeutics Co., Ltd.(TW:6892)
NT$26.00-0.05 (-0.19%)
TW:6892
Taiwan Bio Therapeutics Co., Ltd. Revenue
NT$26.00
At close:-0.05 (-0.19%)
Taiwan Bio Therapeutics Co., Ltd. (6892) Revenue
Taiwan Bio Therapeutics Co., Ltd. Revenue
Taiwan Bio Therapeutics Co., Ltd. had a revenue of 13.58M in the quarter ending Jun 30, 2025, with 18.66%. This bring the company's revenue in the last twelve months to 102.40M, Increased 1.47%. In the fiscal year ending Dec 31, 2025, Taiwan Bio Therapeutics Co., Ltd. had annual revenue of 50.43M with -52.02% growth.
- Revenue (ttm)
- 102.40M
- Revenue Growth
- ―
- P/S Ratio
- 48.47
- Revenue/Employee
- TWD 2,521,300
- Employees
- 20
- Market Cap
- TWD 2.44B
Revenue Chart
Taiwan Bio Therapeutics Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.43M | -54.67M | -52.02% |
| Dec 31, 2024 | 105.09M | 19.62M | 22.96% |
| Dec 31, 2023 | 85.47M | 40.73M | 91.02% |
| Dec 31, 2022 | 44.74M | 17.59M | 64.76% |
| Dec 31, 2021 | 27.16M | 27.16M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.